<DOC>
	<DOC>NCT01627145</DOC>
	<brief_summary>Post-treatment Novmalized Urodynamiz Findings as the Golden Standard of Objective Cure for Female Overactive Bladder Patients Receiving Antimuscarinic Drug and Its Conelations With Voiding Diary, King's Health Quentionaire, Overactive Bladder Sympton Scores and Patient Perception of Bladder Condition.</brief_summary>
	<brief_title>Post-treatment Novmalized Urodynamiz Findings as the Golden Standard of Objective Cure for Female Overactive Bladder Patients Receiving Antimuscarinic Drug</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder, Overactive</mesh_term>
	<mesh_term>Solifenacin Succinate</mesh_term>
	<mesh_term>Muscarinic Antagonists</mesh_term>
	<criteria>female patients within 18 years old to 99 years old with overactive bladder syndrome unwilling or unable to perform testing procedure</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>overactive bladder syndrome</keyword>
	<keyword>derusor overactivity</keyword>
	<keyword>urodynamic studies</keyword>
	<keyword>bladder oversensitivity</keyword>
</DOC>